SCHEMBL6984481

SCHEMBL6984481

CCOC(=O)CN(c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C(=O)OC)cc1C(=N)N)S(=O)(=O)c1cccc2cccnc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 5/20 0.41
ALDH1A1 P00352 4/20 0.40
TP53 P04637 2/20 0.36
POLB P06746 1/20 0.36
GAA P10253 2/20 0.34
TSHR P16473 2/20 0.34
PDK1 Q15118 2/20 0.34
PDK2 Q15119 2/20 0.34
PDK3 Q15120 2/20 0.34
PDK4 Q16654 2/20 0.34
LMNA P02545 2/20 0.33
HPGD P15428 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PTPN2 P17706 1/20 0.33
PTPN1 P18031 1/20 0.33
STAT3 P40763 1/20 0.33
PTPRS Q13332 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984189 0.92 F2 (0.39) F2ALDH1A1TP53POLBGAA
SCHEMBL7958921 0.89 F2 (0.52) F2ALDH1A1TP53POLBGAA
SCHEMBL6978636 0.88 PDK1 (0.36) ALDH1A1TP53POLBTSHRPDK1
SCHEMBL6979175 0.87 USP2 (0.39) ALDH1A1POLBGAATSHRPDK1
SCHEMBL6984478 0.85 F2 (0.42) F2ALDH1A1TP53POLBGAA
SCHEMBL7089640 0.85 PDK1 (0.36) F2ALDH1A1POLBPDK1PDK2
SCHEMBL6980895 0.81 PDK1 (0.40) F2ALDH1A1POLBGAATSHR
SCHEMBL7407618 0.81 ALDH1A1 (0.44) F2ALDH1A1GAATSHRPTPN2
SCHEMBL6984183 0.80 F2 (0.40) F2ALDH1A1TP53POLBGAA
SCHEMBL6982379 0.80 THRB (0.35) F2ALDH1A1TP53POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed